NGS

Charles River Laboratories Accelerates Drug Development with Charles River Rapid Cell Banking Platform

By BiotechReality Business Intelligence Desk
17 September 2026

Charles_River_Laboratories news and statistics

Charles River Laboratories launches its NGS-enabled rapid cell banking platform, cutting production timelines by 40% through automated rapid microbiological testing and in vitro characterization.

Bioinformatics Business Healthcare & Pharmaceuticals News

Roche AXELIOS 1: A Transformative Step for Next-Generation Sequencing Platforms Launched

By BiotechReality Business Intelligence Desk
29 June 2026

Roche News

Roche has officially announced the launch of AXELIOS 1, a next-generation sequencing platform built on proprietary SBX technology, promising same-day whole-genome sequencing with unprecedented speed and accuracy.

Tag: NGS

Charles River Laboratories Accelerates Drug Development with Charles River Rapid Cell Banking Platform

Roche AXELIOS 1: A Transformative Step for Next-Generation Sequencing Platforms Launched

Areas Covered

Discover More

Novo Ozempic 2 mg MACE Analysis Shows 6% Lower Cardiovascular Risk Versus Switching to Mounjaro at EASD 2026

AbbVie Valkai AI Partnership Deploys Purpose-Built AI Across Targeted Clinical Development Areas

Novo HRS-1596 License: Novo Secures Hengrui Pharma’s Oral Once-Weekly GLP-1/GIP Agonist in Deal Worth Up to $2.6 Billion

Merck SPR2015 KRAS G12D Inhibitor Deal Strengthens Oncology Pipeline Through $2.13 Billion Agreement

AbbVie JUVMO (Tavapadon) Wins FDA Approval as First Selective D1/D5 Receptor Agonist for Parkinson’s Disease

Merck Ifinatamab Deruxtecan BLA Withdrawn in Previously Treated ES-SCLC